UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000003872 |
|---|---|
| Receipt number | R000004662 |
| Scientific Title | Pathophysiology of Non-alcoholic fatty liver disease(NAFLD), multi-center clinical trial by JSG-NAFLD |
| Date of disclosure of the study information | 2010/07/10 |
| Last modified on | 2026/07/17 12:11:23 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Pathophysiology of Non-alcoholic fatty liver disease(NAFLD), multi-center clinical trial by JSG-NAFLD
Acronym
Pathophysiology of NAFLD
Scientific Title
Pathophysiology of Non-alcoholic fatty liver disease(NAFLD), multi-center clinical trial by JSG-NAFLD
Scientific Title:Acronym
Pathophysiology of NAFLD
Region
| Japan |
Condition
Condition
Patients with Non-alcoholic fatty liver disease and healthy volunteer
Classification by specialty
| Medicine in general | Hepato-biliary-pancreatic medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To clarify the pathophisiology of NAFLD
Basic objectives2
Others
Basic objectives -Others
To analyse the clinical data of the patients with NAFLD
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
collect yhe clinical data of the patients with NAFLD, and analyse statistically
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with NAFLD and healthy volunteer in our hospital
Key exclusion criteria
Patient who refused participation in this study
Target sample size
2000
Research contact person
Name of lead principal investigator
| 1st name | Hideki |
| Middle name | |
| Last name | Fujii |
Organization
Osaka Metropolitan University
Division name
Department of Nutrition, Graduate School of Human Life and Ecology
Zip code
536-0025
Address
2-1-132, Morinomiya, Joto-ku, Osaka-shi, Osaka 536-8525, JAPAN
TEL
06-6167-1369
o21717h@omu.ac.jp
Public contact
Name of contact person
| 1st name | Hideki |
| Middle name | |
| Last name | Fujii |
Organization
Osaka Metropolitan University
Division name
Department of Nutrition, Graduate School of Human Life and Ecology
Zip code
536-0025
Address
2-1-132, Morinomiya, Joto-ku, Osaka-shi, Osaka 536-8525, JAPAN
TEL
06-6167-1369
Homepage URL
o21717h@omu.ac.jp
Sponsor or person
Institute
Osaka Metropolitan University
Institute
Department
Personal name
Funding Source
Organization
Osaka Metropolitan University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Japan Study Group for NAFLD(JSG-NAFLD)
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethical Committee of Osaka Metropolitan University Graduate School of Medicine
Address
1-4-3 Asahimachi Abenoku Osaka Japan
Tel
06-6645-3435
ethics@med.osaka-cu.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2010 | Year | 07 | Month | 10 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2010 | Year | 03 | Month | 05 | Day |
Date of IRB
Anticipated trial start date
| 2010 | Year | 04 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
1) laboratory tests
2) histopathological finding
3) imaging tests
4) questionnaire
Management information
Registered date
| 2010 | Year | 07 | Month | 05 | Day |
Last modified on
| 2026 | Year | 07 | Month | 17 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004662
